1. Cytomegalovirus retinitis in immunosuppressed hosts;Egbert;Ann. Intern. Med.,1980
2. Bilateral retinal detachment following cytomegalovirus retinitis;Broughton;Arch. Ophthalmol.,1978
3. Longitudinal study of cytomegalovirus retinitis in acquired immunodeficiency syndrome;Gross;Ophthalmology,1990
4. Studies of ocular complications of AIDS. Foscarnet-ganciclovir cytomegalovirus retinitis trial. 2. Mortality;Studies of Ocular Complications of AIDS (SOCA) Research Group in Collaboration with the AIDS Clinical Trials Group (ACTG);N. Engl. J. Med.,1992
5. Hardy, D., Spector, S., Polsky, B., Heath-Chiozzi, M., Holland, G., Freeman, W. R., Heinemann, M. H., Sharuk, G., Feinburg, J., and Power, M.: Safety and efficacy of combined ganciclovir and granulocyte-macrophage colony stimulating factor (GMCSF) in the treatment of cytomegalovirus retinitis in AIDS patients. Rationale for and preliminary results from a phase II randomized trial (ACTG 073). In Spector, S.A. (ed.): Ganciclovir Therapy for Cytomegalovirus Infection. New York, New York, Marcel Dekker, Inc., pp. 197–213.